Predictive methylation signature for gemcitabine sensitivity in pancreatic ductal adenocarcinoma: A pathway to personalized treatment.

被引：0
|
作者：
Sherpally, Deepak
Jeepalyam, Sravan
Puram, Harshitha
Manne, Ashish
机构：
[1] Metropolitan Hosp Ctr, New York, NY USA
[2] Stormont Vail Hlth, Topeka, KS USA
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.768
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：768 / 768
页数：1
相关论文
共 50 条
  • [41] Surgical Treatment of Pancreatic Ductal Adenocarcinoma
    Wei, Kongyuan
    Hackert, Thilo
    CANCERS, 2021, 13 (08)
  • [42] The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective
    Peretti, Umberto
    Zanon, Silvia
    Michele, Reni
    ENDOSCOPIC ULTRASOUND, 2017, 6 : S66 - S68
  • [43] The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities
    Tesfaye, Anteneh A.
    Kamgar, Mandana
    Azmi, Asfar
    Philip, Philip A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (02) : 131 - 148
  • [44] Combination of gemcitabine and cytidine deaminase inhibitor: A breakthrough cocktail for the treatment of pancreatic ductal adenocarcinoma.
    Patki, Manali
    Saraswat, Aishwarya
    Bhutkar, Shraddha
    Dukhande, Vikas
    Patel, Ketankumar
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Preclinical treatment of pancreatic ductal adenocarcinoma using targetable self-assembled gemcitabine nanoparticles
    Fu, Zhang
    CANCER RESEARCH, 2020, 80 (16)
  • [46] Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
    Taherian, Mehran
    Wang, Hua
    Wang, Huamin
    CELLS, 2022, 11 (19)
  • [47] Signature protein biomarkers in serum for diagnosis of pancreatic ductal adenocarcinoma
    Lindgaard, S. C.
    Maag, E.
    Chen, I.
    Johansen, A. Z.
    Hansen, C. P.
    Hasselby, J. P.
    Jensen, B. V.
    Bojesen, S. E.
    Nielsen, K. R.
    Nielsen, D. L.
    Johansen, J. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S945 - S945
  • [48] Pancreatic Ductal Adenocarcinoma is Associated with a Distinct Urinary Metabolomic Signature
    Davis, Vanessa W.
    Schiller, Daniel E.
    Eurich, Dean
    Bathe, Oliver F.
    Sawyer, Michael B.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S415 - S423
  • [49] A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma
    Sahni, Sumit
    Pandya, Advait R.
    Hadden, William J.
    Nahm, Christopher B.
    Maloney, Sarah
    Cook, Victoria
    Toft, James A.
    Wilkinson-White, Lorna
    Gill, Anthony J.
    Samra, Jaswinder S.
    Dona, Anthony
    Mittal, Anubhav
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (06) : 1508 - 1518
  • [50] Pancreatic Ductal Adenocarcinoma is Associated with a Distinct Urinary Metabolomic Signature
    Vanessa W. Davis
    Daniel E. Schiller
    Dean Eurich
    Oliver F. Bathe
    Michael B. Sawyer
    Annals of Surgical Oncology, 2013, 20 : 415 - 423
12345